Welcome to LookChem.com Sign In|Join Free

CAS

  • or

346718-87-4

346718-87-4

Post Buying Request

346718-87-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

346718-87-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 346718-87-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,6,7,1 and 8 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 346718-87:
(8*3)+(7*4)+(6*6)+(5*7)+(4*1)+(3*8)+(2*8)+(1*7)=174
174 % 10 = 4
So 346718-87-4 is a valid CAS Registry Number.

346718-87-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-CHLOROPHENYL)SULFONYL(4-IODO)ANILINE

1.2 Other means of identification

Product number -
Other names 4-Chlor-benzolsulfonsaeure-(4-chlor-N-methyl-anilid)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:346718-87-4 SDS

346718-87-4Relevant articles and documents

5-LIPOXYGENASE INHIBITORS

-

Page/Page column 34, (2009/12/28)

The use of compounds of the formula (I) Ar1-L1-Ar2-L2-C(R3)(R4)N(OR1)C(=Y)-R2 (I) where Y is selected from O or S; R1 is H, a salt or readily hydrolysable s

Polymer-assisted, multi-step solution phase synthesis and biological screening of histone deacetylase inhibitors

Bapna, Akanksha,Vickerstaffe, Emma,Warrington, Brian H.,Ladlow, Mark,Fan, Tai-Ping D.,Ley, Steven V.

, p. 611 - 620 (2007/10/03)

The polymer-assisted solution phase synthesis (PASP) of an array of histone deacetylase (HDAc) inhibitors is described. HDAc inhibitors have considerable potential as new anti-proliferative agents. Selected compounds were shown to inhibit both human endothelial cell proliferation, and the formation of tubules (neovascularisation) in an in vitro model of angiogenesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 346718-87-4